Tag Archive | "Celgene"

Mesoblast banks $45mn financing from Celgene

Tags: , ,

Mesoblast has entered into an Agreement with Celgene Read the full story

Celgene and Open Monoclonal Tech in OmniAb alliance

Tags: , ,

Open Monoclonal Technology announced license that provides Celgene with unlimited access to OMT’s proprietary OmniRat, OmniMouse and OmniFlic platforms for generation of human antibody therapeutics Read the full story

Celgene licenses AG-120 from Agios

Tags: , , ,

Agios Pharmaceuticals announced that its collaboration partner Celgene has agreed that it will exercise its option to obtain an exclusive license outside the United States for AG-120 Read the full story

Sutro and Celgene sign a pharma deal for $1 billion

Tags: , , ,

Sutro Biopharma has entered a pharma deal and option agreement with Celgene to discover and develop antibodies and antibody drug conjugates. Read the full story

BMS and Celgene become pharma partners for evaluating cancer drugs

Tags: , , , ,

Bristol-Myers Squibb and Celgene become a pharma partners for evaluating the efficacy of combination treatment using  OPDIVO and ABRAXANE. Read the full story

NanoString signs a pharma deal with Celegene

Tags: , ,

NanoString Technologies entered into a pharma deal with Celgene to develop a companion diagnostic assay using the nCounter Analysis System to support the clinical validation of REVLIMID for treatment of Diffuse Large B-Cell Lymphoma for $45 million. Read the full story

Top 50 Pharma (top pharmaceutical companies)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story


Tags: , ,

Celgene is a top pharmaceutical company, incorporated in Delaware and headquartered in Summit, New Jersey Read the full story

Celgene and Nogra enter into a pharma alliance for Crohn’s Disease

Tags: , ,

Celgene entered into a pharma alliance for a global license agreement with Nogra Pharma to develop and commercialize GED-0301, an oral antisense DNA oligonucleotide targeting Smad7 mRNA for the treatment of moderate-to-severe Crohn’s disease and other indications. Read the full story

Forma and Celgene announced a second pharma partnering for unmet medical needs

Tags: , , , ,

FORMA Therapeutics announced a second strategic pharma partnering collaboration and option agreement with Celgene. Read the full story

RSS FeedLinked InTwitter

Latest Tweets